← Every company
Repligen Corp SEC Filings
What Repligen Corp has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
RGEN overview →Filings on file
132
since Nov 3, 2016
Warning signs
3
latest Mar 3, 2025
Last results
Jul 28, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Oct 6, 2026 | Acquisition or sale completed 8-K | Read ↗ |
| Aug 25, 2026 | Merger vote or registration S-4 | Read ↗ |
| May 31, 2019 | Acquisition or sale completedMaterial agreementUnregistered share sale 8-K | Read ↗ |
| Aug 3, 2017 | Acquisition or sale completedUnregistered share sale 8-K | Read ↗ |
| Mar 1, 2017 | Acquisition or sale completed 8-K/A | Read ↗ |
| Dec 15, 2016 | Acquisition or sale completedMaterial agreement 8-K | Read ↗ |
Source: Repligen Corp's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on RGEN
Company overviewEverything on RGEN in one place, with the price.Insider tradingWhat RGEN's own officers and directors buy and sell.Planned salesSales RGEN insiders have filed notice of.Who owns itEvery manager reporting a position in RGEN.Funds holding itWhich funds and ETFs hold RGEN, and how big a bet.Federal contractsWhat federal agencies pay RGEN.PatentsWhat RGEN is filing at the patent office.